Ironwood Financial’s GenMark Diagnostics, Inc GNMK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-36,490
Closed -$533K 586
2020
Q4
$533K Sell
36,490
-2,500
-6% -$33.1K 0.2% 71
2020
Q3
$554K Hold
38,990
0.28% 46
2020
Q2
$574K Hold
38,990
0.31% 42
2020
Q1
$161K Buy
38,990
+35,436
+997% +$166K 0.11% 39
2019
Q4
$17K Hold
3,554
0.01% 227
2019
Q3
$22K Hold
3,554
0.01% 197
2019
Q2
$23K Hold
3,554
0.01% 191
2019
Q1
$25K Hold
3,554
0.01% 174
2018
Q4
$17K Sell
3,554
-450
-11% -$2.34K 0.01% 201
2018
Q3
$29K Sell
4,004
-510
-11% -$3.74K 0.02% 162
2018
Q2
$29K Hold
4,514
0.02% 129
2018
Q1
$25K Buy
4,514
+964
+27% +$4.79K 0.03% 120
2017
Q4
$15K Hold
3,550
0.01% 153
2017
Q3
$34K Hold
3,550
0.02% 107
2017
Q2
$42K Hold
3,550
0.03% 91
2017
Q1
$46K Hold
3,550
0.03% 89
2016
Q4
$43K Hold
3,550
0.03% 93
2016
Q3
$42K Hold
3,550
0.03% 95
2016
Q2
$31K Sell
3,550
-280
-7% -$1.92K 0.02% 112
2016
Q1
$20K Buy
+3,830
New +$21.3K 0.02% 137
2015
Q3
$30K Buy
3,830
+720
+23% +$6.66K 0.01% 143
2015
Q2
$28K Hold
3,110
0.01% 146
2015
Q1
$40K Sell
3,110
-650
-17% -$8.5K 0.02% 122
2014
Q4
$51K Buy
+3,760
New +$42K 0.03% 101

Other funds holding GNMK

Ironwood Financial's GNMK Position: Q1 2021 in Review

Ironwood Financial sold out of GenMark Diagnostics, Inc (GNMK) in Q1 2021, closing a stake of 36,490 shares — an estimated $533K sold.

Ironwood Financial first reported a position in GNMK in Q4 2014 and held it in 24 quarters. The position peaked at $574K in Q2 2020. 164 funds tracked by Wall St. Rank hold GNMK as of Q1 2021.

  • Ironwood Financial reported no remaining GenMark Diagnostics, Inc position as of Q1 2021 after selling out during the quarter.
  • Ironwood Financial sold 36,490 GenMark Diagnostics, Inc shares in Q1 2021, an estimated $533K.
  • Ironwood Financial first reported a position in GenMark Diagnostics, Inc in Q4 2014 and held it in 24 quarters.
  • Ironwood Financial's GenMark Diagnostics, Inc position peaked at $574K in Q2 2020.
  • 164 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q1 2021.

Based on Ironwood Financial's 13F filing for Q1 2021, filed 28 Apr 2021.